I am a cell culture scientist with expertise in neuroscience and cell biology, specializing in neurodegeneration, targeted therapeutics, and high-throughput assay development. During my PhD, I utilized patient-iPSC derived neurons and glia to screen therapeutics in order to improve neuronal health and function in neurodegeneration. These experiments revealed critical differences in treatment efficacy between diseases that share primary patient phenotypes, and further differences based on specific mutations between patients with the same disease. As the rate of neurodegenerative disease diagnosis continues to rise, these studies highlight the importance of patient-specific high-throughput therapeutic screens. Throughout my academic career, I gained invaluable experience in iPSC culture, directed differentiations of iPSCs to neurons and glia, gene therapies and targeted genetic editing, creating stabilized reporter lines, and high-throughput assay development. I also was trained and funded by the Center for Immunology at MCW which gave me additional insight into neuroimmunological dysfunction and assays to assess cell secretomes. Upon the completion of my PhD, I transitioned to industry where I lead novel differentiation protocol development for cells including oligodendrocyte precursor cells (OPCs). OPCs are glial cells particularly important in multiple sclerosis, a major neuroimmunological disorder wherein myelin produced by oligodendrocytes is degraded. In my current role, I am able to combine my unique training in neuroimmunological therapeutics, iPSC culture and differentiations, and high-throughput assay development. Working alongside other passionate scientists to develop a myelination screening platform of iPSC-derived OPCs is both intellectually thrilling and personally fulfilling. This project supports my professional goal of creating advanced in vitro therapeutic screening platforms to allow for patient-specific treatment development. This approach will allow for better treatment efficacy across disease to improve patient outcomes and lifespans.